ID   OM431
AC   CVCL_J308
SY   OM-431
DR   Wikidata; Q54932013
RX   PubMed=1531323;
RX   PubMed=6386741;
RX   PubMed=7641843;
RX   PubMed=7573309;
RX   PubMed=16772116;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=1531323).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=1531323;
RA   Parry R.L., Chin T.-W., Epstein J., Hudson P.L., Powell D.M.,
RA   Donahoe P.K.;
RT   "Recombinant human Mullerian inhibiting substance inhibits human
RT   ocular melanoma cell lines in vitro and in vivo.";
RL   Cancer Res. 52:1182-1186(1992).
//
RX   PubMed=6386741;
RA   Albert D.M., Ruzzo M.A., McLaughlin M.A., Robinson N.L., Craft J.L.,
RA   Epstein J.;
RT   "Establishment of cell lines of uveal melanoma. Methodology and
RT   characteristics.";
RL   Invest. Ophthalmol. Vis. Sci. 25:1284-1299(1984).
//
RX   PubMed=7641843; DOI=10.1016/S0014-4835(05)80002-8;
RA   Logani S., Cho A.S., Su L.D., Withers H.R., McBride W.H., Hall M.O.,
RA   Lee D.A., Milani J.K., Straatsma B.R.;
RT   "Effects of gamma radiation on the OM431 human ocular melanoma cell
RT   line.";
RL   Exp. Eye Res. 60:603-605(1995).
//
RX   PubMed=7573309; DOI=10.1016/S0002-9394(14)72665-0;
RA   Logani S., Cho A.S., Ali B.H., Withers H.R., McBride W.H.,
RA   Kozlov K.L., Hall M.O., Lee D.A., Straatsma B.R.;
RT   "Single-dose compared with fractionated-dose radiation of the OM431
RT   choroidal melanoma cell line.";
RL   Am. J. Ophthalmol. 120:506-510(1995).
//
RX   PubMed=16772116; DOI=10.1016/j.cancergencyto.2005.11.016;
RA   White J.S., Becker R.L., McLean I.W., Director-Myska A.E., Nath J.;
RT   "Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.";
RL   Cancer Genet. Cytogenet. 168:11-21(2006).
//